How to Get Ketamine Therapy Covered by Insurance

You've done the research. You know ketamine therapy might help where other treatments haven't. But now you're stuck on a different kind of problem: figuring out how to actually pay for it. Between confusing insurance policies, prior authorization requirements, and pricing that varies wildly depending on who you ask, affording treatment can feel like its own obstacle course.

You're not alone. Many people try antidepressant after antidepressant without finding real relief, and for a significant number, that pattern has a clinical name: treatment-resistant depression (TRD). If that sounds familiar, you're likely asking the same coverage questions right now.

The bottom line: Many major insurers cover one form of ketamine treatment: Spravato (esketamine nasal spray), which is FDA-approved for TRD and major depression with acute suicidal ideation. Coverage varies by plan and state and typically requires prior authorization. IV and oral ketamine rarely have traditional insurance coverage, though affordable alternatives exist, including at-home sublingual programs with provider insurance partnerships.

What Insurance Coverage for Ketamine Therapy Looks Like Right Now

The coverage landscape has a sharp dividing line, and it comes down to FDA approval.

Spravato (esketamine) is FDA-approved for two indications: treatment-resistant depression and major depressive disorder (MDD) with acute suicidal ideation or behavior. It must be administered in a certified medical setting under the FDA's Risk Evaluation and Mitigation Strategy (REMS) requirements. You can verify the current indications in the official FDA label.

IV ketamine infusions and oral or sublingual ketamine are typically prescribed off-label for depression. Off-label prescribing can be clinically appropriate, but many insurers classify off-label ketamine for mental health conditions as experimental and won't cover it. If you want insurance to help pay for ketamine-based treatment through traditional coverage channels, Spravato is the most realistic path.

That said, Innerwell has built insurance partnerships for at-home sublingual ketamine that bypass the Spravato authorization process entirely. If you already know you're interested in at-home or sublingual ketamine rather than Spravato, you can skip to the cost comparison below.

What You Need to Qualify for Coverage

Most major insurers look for the same core criteria, though the specifics vary by plan. Medicaid requirements can differ more substantially.

You'll generally need a confirmed diagnosis of treatment-resistant MDD, a documented history of inadequate response to at least two antidepressants, and a recent depression severity score. If you haven't been formally diagnosed with TRD, a psychiatrist can establish this based on your treatment history.

For the medication history, each antidepressant trial typically needs to have lasted six to eight weeks at adequate doses, depending on the plan. Acceptable classes often include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), bupropion, and tricyclics. Before you start the process, gather records for each medication showing the drug name and dosage, start and end dates, your response, and why it wasn't adequate. Incomplete documentation is the single most common reason authorizations get denied. The good news: it's fixable.

For the severity score, insurers accept validated tools like the Patient Health Questionnaire (PHQ-9), Montgomery–Åsberg Depression Rating Scale (MADRS), or Hamilton Depression Rating Scale (HAMD), depending on your plan.

You'll also need to receive treatment at a REMS-certified facility, and many plans require a psychiatrist to prescribe or be involved in your care.

If you're not sure whether your situation qualifies, this guide to ketamine eligibility walks through what providers typically look for.

How to Get Prior Authorization Approved

Many insurers require prior authorization for Spravato. Decisions are often made within one to two weeks once the packet is complete, though timelines vary by plan.

Find a REMS-certified treatment center first. Many employ insurance coordinators who handle authorization paperwork, know what each insurer requires, and manage appeals if needed. Navigating this alone is possible but significantly harder.

Build your documentation package. Use the medication records you gathered above. If records from previous providers are incomplete, ask your current psychiatrist to write a summary letter documenting your treatment history. Thorough documentation is the difference between approval and denial.

Get a baseline assessment on file. If you haven't had a PHQ-9, MADRS, or HAMD assessment recently, schedule one before submitting authorization. Many plans will deny your request without a documented baseline score.

Confirm a psychiatrist is involved. Most plans require a psychiatrist to prescribe esketamine or at least be consulted on the treatment plan. If your prescriber is a primary care clinician or nurse practitioner, they may need to document psychiatric consultation.

Once approved, authorization may last 6 to 12 months depending on your plan before requiring renewal. Renewal requires updated documentation that symptoms are improving and ongoing treatment remains medically necessary.

What to Do When You're Denied

A denial is frustrating, especially when you've already spent months or years trying to find something that works. But it isn't the end. The Affordable Care Act guarantees your right to appeal many coverage denials through internal and external review processes. The Centers for Medicare & Medicaid Services explains your appeal rights in detail.

File an internal appeal first. This is usually required before external review. Check your Explanation of Benefits (EOB) or call your insurer to confirm your appeal deadline. Your appeal should include a letter from your psychiatrist explaining medical necessity, your complete medication history with dosages and dates, and your baseline and current depression assessment scores.

Use mental health parity as leverage. The Mental Health Parity and Addiction Equity Act generally requires that limitations for mental health benefits be no more restrictive than those for medical or surgical benefits. If your plan applies stricter standards to TRD than it would to a comparable medical condition, say so clearly in your appeal. The U.S. Department of Labor offers parity resources for building your case.

Request a peer-to-peer review. This allows your psychiatrist to speak directly with the insurance company's medical director, which can resolve denials that stem from misunderstandings or missing details.

If internal appeals fail, pursue external review. An independent review organization evaluates your case, and their decision may be binding. Your state insurance commissioner's office can also help with complaints and parity enforcement.

What Each Format Costs and How to Pay

If the Spravato authorization path doesn't fit your situation, or you'd prefer a different format, here's how the three main options compare on cost and access.

Factor

At-Home Sublingual (Innerwell)

Spravato (Esketamine)

IV Infusions

Insurance coverage

Available through Innerwell's insurance partnerships (CA, NY)

Often covered with prior authorization (varies by plan)

Not typically covered

Typical cost per session

$54–$75 (insurance) / $83–$125 (self-pay)

Varies with plan; prior authorization required

Several hundred dollars, sometimes over $1,000

Setting

Home

REMS-certified clinic

Infusion clinic

Therapeutic support

Preparation and integration built in

Post-dose monitoring

Varies by clinic

Spravato may cost less overall when fully covered by insurance. The manufacturer's withMe savings program can reduce medication costs to as little as $10 per treatment for people with commercial or private insurance. You can check eligibility at spravato.com.

IV ketamine infusions vary widely by geography and rarely have traditional insurance coverage. Some clinics provide superbills you can submit to your insurer for partial out-of-network reimbursement, and a small number of regional or employer-sponsored plans have begun covering IV ketamine for depression under criteria similar to Spravato. If you're considering this route, check directly with your plan before committing. Veterans may also be able to access ketamine-based treatments through the VA system at some facilities, though availability varies by location.

Sublingual ketamine programs can be substantially more affordable than in-clinic infusions, particularly with insurance partners. Many people respond well to sublingual formats when paired with integration therapy.

For a closer look at format trade-offs, see this Spravato vs ketamine comparison or this breakdown of at-home vs infusion options.

How Innerwell's At-Home Ketamine Therapy Works

Many people land on at-home sublingual ketamine because it's often the most affordable format, skips Spravato's prior authorization process entirely, and fits into your life without repeated clinic visits.

Innerwell provides at-home ketamine therapy with direct clinician access, licensed therapist support before and after each session, and structured mood tracking. This isn't ketamine dropped off with minimal supervision. Every clinician holds a Master's or Doctoral degree and is trained in psychedelic medicine.

The process:

1. Evaluation: A psychiatric assessment determines whether ketamine therapy is appropriate for your situation, including a review of your treatment history, current symptoms, and any potential contraindications.
2. Delivery: Sublingual ketamine tablets are shipped from a licensed pharmacy after clinical approval, with precise dosing guidance and direct clinician access through secure messaging.
3. Preparation and integration: Ketamine opens a window of neuroplasticity; integration therapy helps you use it intentionally. Before and after each session, licensed therapists help you process what comes up and build lasting change.
4. Ongoing monitoring: Your care team tracks mood, symptoms, and progress with regular check-ins and real-time dosage adjustments.

Pricing: Through insurance partnerships in California and New York, sessions start at $54 to $75. The Foundation Plan (8 sessions) costs $599 with insurance; the Extended Plan (24 sessions) costs $1,299 with insurance. Self-pay runs $83 to $125 per session, with the Foundation Plan at $998 and the Extended Plan at $1,999.

Program outcomes: In Innerwell's clinical data, 69% of participants saw meaningful reduction in depression symptoms after 10 weeks. 60% experienced reduced anxiety. 87% reported improvement within four weeks, and the program holds a 4.7 out of 5 patient rating.

Take the free assessment to see if ketamine therapy might work for you.

Frequently Asked Questions

Does Medicare cover any form of ketamine therapy?

Medicare Part B generally pays 80% of the Medicare-approved amount for covered outpatient services after the Part B deductible, and Spravato typically qualifies when administered in an eligible setting and medical necessity criteria are met. Your out-of-pocket cost depends on the setting, whether the provider accepts assignment, and whether you have supplemental coverage. Medicare typically does not cover IV ketamine infusions for depression because the use is off-label. Medicare Advantage plans often have similar medical-necessity requirements.

Can I get ketamine covered for PTSD, anxiety, or OCD?

Spravato's FDA approval covers treatment-resistant depression and major depression with acute suicidal ideation, not PTSD, anxiety, or OCD specifically. Off-label ketamine for these conditions follows the same coverage pattern as IV ketamine for depression: traditional insurance rarely covers it, but at-home sublingual programs with provider insurance partnerships may still be accessible.

Can I use HSA or FSA funds for ketamine therapy?

Health savings account (HSA) and flexible spending account (FSA) funds can often be used for qualified medical expenses as defined by the IRS, including some prescribed treatments that aren't reimbursed by insurance. Eligibility for off-label therapies depends on your specific plan rules, so verify with your administrator and keep detailed receipts.

What if my state's Medicaid program doesn't cover Spravato?

State Medicaid coverage for Spravato varies significantly. The most direct way to get an accurate answer is to call your state Medicaid office or managed care plan and ask for their Spravato prior authorization criteria. If Medicaid won't cover Spravato in your state, at-home sublingual ketamine programs may still be an option through self-pay.